![George Kassiotis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Kassiotis
Amministratore Delegato presso Omega Navigation Enterprises, Inc.
Posizioni attive di George Kassiotis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Omega Navigation Enterprises, Inc.
![]() Omega Navigation Enterprises, Inc. Marine ShippingTransportation Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece. | Direttore/Membro del Consiglio | 28/02/2005 | - |
Amministratore Delegato | 28/02/2005 | - | |
Presidente | 28/02/2005 | - |
Storia della carriera di George Kassiotis
Precedenti posizioni note di George Kassiotis
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ervaxx Ltd.
![]() Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Fondatore | - | - |
Formazione di George Kassiotis
Université Paris 1 Panthéon-Sorbonne | Undergraduate Degree |
University of London | Graduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Grecia | 2 |
Francia | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Settori
Consumer Services | 3 |
Transportation | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Omega Navigation Enterprises, Inc.
![]() Omega Navigation Enterprises, Inc. Marine ShippingTransportation Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece. | Transportation |
Ervaxx Ltd.
![]() Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Health Technology |
- Borsa valori
- Insiders
- George Kassiotis
- Esperienza